Identification of potential bladder cancer drug targets through Mendelian randomization and molecular docking

Abstract Bladder cancer is a common and lethal malignancy with high treatment costs due to frequent recurrence and prolonged therapy. Despite therapeutic advances, many patients develop drug-resistant metastatic disease, underscoring the need for new treatments. Using the STROBE-MR guidelines, we pe...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Chengwei Bi, Kexun Li, Yong Yang, Yuanlong Shi, Guoying Zhang, Bing Zhao, Yuanpeng Duan, Yapeng Xing, Wei Luo, Libo Yang, Yu Zhang, Yunchao Huang
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Springer 2025-11-01
Ráidu:	Discover Oncology
Fáttát:	Bladder cancer Mendelian randomization Drug targets Genetics
Liŋkkat:	https://doi.org/10.1007/s12672-025-03929-7
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!